Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | SA53-OS |
Synonyms | |
Therapy Description |
Limited information is currently available on SA53-OS, a putative MDM2 inhibitor (Sep 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
SA53-OS | SA53 OS|SA53OS|SA53-MDM2 | MDM2 Inhibitor 23 | Limited information is currently available on SA53-OS, a putative MDM2 inhibitor (Sep 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06578624 | Phase Ib/II | SA53-OS | Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors | Not yet recruiting | USA | 0 |